Abstract
The domestic pig shares many genetic, anatomical and physiological similarities to humans and is thus considered to be a suitable organ donor for xenotransplantation. However, prior to clinical application of porcine xenografts, three major hurdles have to be overcome: (1) various immunological rejection responses, (2) physiological incompatibilities between the porcine organ and the human recipient and (3) the risk of transmitting zoonotic pathogens from pig to humans. With the introduction of genetically engineered pigs expressing high levels of human complement regulatory proteins or lacking expression of α-Gal epitopes, the HAR can be consistently overcome. However, none of the transgenic porcine organs available to date was fully protected against the binding of anti-non-Gal xenoreactive natural antibodies. The present view is that long-term survival of xenografts after transplantation into primates requires additional modifications of the porcine genome and a specifically tailored immunosuppression regimen compliant with current clinical standards. This requires the production and characterization of multi-transgenic pigs to control HAR, AVR and DXR. The recent emergence of new sophisticated molecular tools such as Zinc-Finger nucleases, Transcription-activator like endonucleases, and the CRISPR/Cas9 system has significantly increased efficiency and precision of the production of genetically modified pigs for xenotransplantation. Several candidate genes, incl. hTM, hHO-1, hA20, CTLA4Ig, have been explored in their ability to improve long-term survival of porcine xenografts after transplantation into non-human primates. This review provides an update on the current status in the production of multi-transgenic pigs for xenotransplantation which could bring porcine xenografts closer to clinical application.
Similar content being viewed by others
References
Ahrens HE, Petersen B, Herrmann D, Lucas-Hahn A, Hassel P, Ziegler M et al (2015a) siRNA mediated knockdown of tissue factor expression in pigs for xenotransplantation. Am J Transplant 15:1407–1414
Ahrens HE, Petersen B, Ramackers W, Petkov S, Herrmann D, Hauschild-Quintern J et al (2015b) Kidneys from α1,3-galactosyltransferase knockout/human heme oxygenase-1/human A20 transgenic pigs are protected from rejection during ex vivo perfusion with human blood. Transplant Direct 1:1–8
Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T et al (1997) Accommodation of vascularized xenografts: expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3:196–204
Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F et al (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148–18153
Banz Y, Cung T, Korchagina EY, Bovin NV, Haeberli A, Rieben R (2005) Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood. Xenotransplantation 12:434–443
Brune B, Ullrich V (1987) Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32:497–504
Byrne GW, Stalboerger PG, Davila E, Heppelmann CJ, Gazi MH, McGregor HC et al (2008) Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 15:268–276
Byrne GW, Stalboerger PG, Du Z, Davis TR, McGregor CG (2011) Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 91:287–292
Byrne GW, Du Z, Stalboerger P, Kogelberg H, McGregor CG (2014) Cloning and expression of porcine beta1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation 21:543–554
Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M et al (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA 109:17382–17387
Chou H, Takematsu H, Diaz S, Iber J, Nickerson E, Wright KL et al (1998) A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 95:11751–11756
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823
Cooper DK, Satyananda V, Ekser B, van der Windt DJ, Hara H, Ezzelarab MB et al (2014) Progress in pig-to-non-human primate transplantation models (1998–2013): a comprehensive review of the literature. Xenotransplantation 21:397–419
Crikis S, Cowan PJ, d’Apice AJ (2006) Intravascular thrombosis in discordant xenotransplantation. Transplantation 82:1119–1123
Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S et al (2002) Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20:251–255
d’Apice AJ, Cowan PJ (2008) Xenotransplantation: the next generation of engineered animals. Transpl Immunol 21:111–115
Davila E, Byrne GW, LaBreche PT, McGregor HC, Schwab AK, Davies WR et al (2006) T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 13:31–40
Esquivel EL, Maeda A, Eguchi H, Asada M, Sugiyama M, Manabe C et al (2015) Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G. Transpl Immunol 32:109–115
Estrada JL, Martens G, Li P, Adams A, Newell KA, Ford ML et al (2015) Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation 22:194–202
Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32:279–284
Fujimura T, Kurome M, Murakami H, Takahagi Y, Matsunami K, Shimanuki S et al (2004) Cloning of the transgenic pigs expressing human decay accelerating factor and N-acetylglucosaminyltransferase III. Cloning Stem Cells 6:294–301
Galili U (1993) Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 14:480–482
Garrels W, Mates L, Holler S, Dalda A, Taylor U, Petersen B et al (2011) Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS ONE 6:e23573
Goto M, Groth CG, Nilsson B, Korsgren O (2004) Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood-mediated inflammatory reaction. Xenotransplantation 11:195–202
Guilinger JP, Thompson DB, Liu DR (2014) Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32:577–582
Hai T, Teng F, Guo R, Li W, Zhou Q (2014) One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res 24:372–375
Harris DG, Quinn KJ, French BM, Schwartz E, Kang E, Dahi S et al (2015) Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation 22:102–111
Hauschild J, Petersen B, Santiago Y, Queisser AL, Carnwath JW, Lucas-Hahn A et al (2011) Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA 108:12013–12017
Hauschild-Quintern J, Petersen B, Queisser AL, Lucas-Hahn A, Schwinzer R, Niemann H (2013a) Gender non-specific efficacy of ZFN mediated gene targeting in pigs. Transgenic Res 22:1–3
Hauschild-Quintern J, Petersen B, Cost GJ, Niemann H (2013b) Gene knockout and knockin by zinc-finger nucleases: current status and perspectives. Cell Mol Life Sci 70:2969–2983
Horvath-Arcidiacono JA, Porter CM, Bloom ET (2006) Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 13:318–327
Ide K, Ohdan H, Kobayashi T, Hara H, Ishiyama K, Asahara T (2005) Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 12:181–188
Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R (1997) Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 63:1318–1330
Iwase H, Ezzelarab MB, Ekser B, Cooper DK (2014) The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options. Xenotransplantation 21:201–220
Izsvak Z, Chuah MK, Vandendriessche T, Ivics Z (2009) Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors. Methods 49:287–297
Jaattela M, Mouritzen H, Elling F, Bastholm L (1996) A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 156:1166–1173
Kim D, Bae S, Park J, Kim E, Kim S, Yu HR et al (2015) Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods 12:237–243
Klymiuk N, van Buerck L, Bahr A, Offers M, Kessler B, Wuensch A et al (2012) Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 61:1527–1532
Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM et al (2005) Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11:29–31
Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS et al (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089–1092
LaMattina JC, Burdorf L, Zhang T, Rybak E, Cheng X, Munivenkatappa R et al (2014) Pig-to-baboon liver xenoperfusion utilizing GalTKO.hCD46 pigs and glycoprotein Ib blockade. Xenotransplantation 21:274–286
Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobert E et al (2005) Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 5:443–453
Lee KF, Salvaris EJ, Roussel JC, Robson SC, d’Apice AJ, Cowan PJ (2008) Recombinant pig TFPI efficiently regulates human tissue factor pathways. Xenotransplantation 15:191–197
Lee KG, Lee H, Ha JM, Lee YK, Kang HJ, Park CG et al (2012) Increased human tumor necrosis factor-alpha levels induce procoagulant change in porcine endothelial cells in vitro. Xenotransplantation 19:186–195
Li P, Estrada JL, Burlak C, Montgomery J, Butler JR, Santos RM et al (2015) Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. Xenotransplantation 22:20–31
Lillico SG, Proudfoot C, Carlson DF, Stverakova D, Neil C, Blain C et al (2013) Live pigs produced from genome edited zygotes. Sci Rep 3:2847
Lin CC, Chen D, McVey JH, Cooper DK, Dorling A (2008) Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 86:702–709
Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB et al (2004) Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 11:171–183
Luther T, Flossel C, Mackman N, Bierhaus A, Kasper M, Albrecht S et al (1996) Tissue factor expression during human and mouse development. Am J Pathol 149:101–113
Lutz J, le Luong A, Strobl M, Deng M, Huang H, Anton M et al (2008) The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl) 86:1329–1339
Ma X, Ye B, Gao F, Liang Q, Dong Q, Liu Y et al (2012) Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction. Cell Transplant 21:61–71
Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29:143–148
Miwa Y, Kobayashi T, Nagasaka T, Liu D, Yu M, Yokoyama I et al (2004) Are N-glycolylneuraminic acid (Hanganutziu–Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 11:247–253
Mueller BM, Reisfeld RA, Edgington TS, Ruf W (1992) Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 89:11832–11836
Niemann H, Verhoeyen E, Wonigeit K, Lorenz R, Hecker J, Schwinzer R et al (2001) Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Transplantation 72:1898–1906
Oropeza M, Petersen B, Carnwath JW, Lucas-Hahn A, Lemme E, Hassel P et al (2009) Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 16:522–534
Osterud B, Rapaport SI (1977) Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74:5260–5264
Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N et al (2008) Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 18:818–830
Parry GC, Erlich JH, Carmeliet P, Luther T, Mackman N (1998) Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 101:560–569
Petersen B, Niemann H (2015) Molecular scissors and their application in genetically modified farm animals. Transgenic Res 24:381–396
Petersen B, Carnwath JW, Niemann H (2009a) The perspectives for porcine-to-human xenografts. Comp Immunol Microbiol Infect Dis 32:91–105
Petersen B, Ramackers W, Tiede A, Lucas-Hahn A, Herrmann D, Barg-Kues B et al (2009b) Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation 16:486–495
Petersen B, Ramackers W, Lucas-Hahn A, Lemme E, Hassel P, Queisser AL et al (2011) Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation 18:355–368
Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH et al (2003) Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299:411–414
Reyes LM, Estrada JL, Wang ZY, Blosser RJ, Smith RF, Sidner RA et al (2014) Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease. J Immunol 193:5751–5757
Rieben R, Seebach JD (2005) Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends Immunol 26:2–5
Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d’Apice AJ, Cowan PJ (2008) Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 8:1101–1112
Ryter SW, Choi AM (2013) Carbon monoxide: present and future indications for a medical gas. Korean J Intern Med 28:123–140
Salama A, Evanno G, Harb J, Soulillou JP (2015) Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation. Xenotransplantation 22:85–94
Scobie L, Padler-Karavani V, Le Bas-Bernardet S, Crossan C, Blaha J, Matouskova M et al (2013) Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 191:2907–2915
Song HY, Rothe M, Goeddel DV (1996) The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA 93:6721–6725
Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R et al (1991) Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127–134
Tenhunen R, Ross ME, Marver HS, Schmid R (1970) Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry 9:298–303
Mohiuddin MM, Singh AK, Corcoran PC, Hoyt RF, Thomas, ML, III, Ayares D, et al. (2014) Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J Thorac Cardiovasc Surg 148:1106–1113 (discussion 1113–1114)
Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583–1587
Tsai SQ, Wyvekens N, Khayter C, Foden JA, Thapar V, Reyon D et al (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32:569–576
Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S et al (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646–651
Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11:636–646
Weiss EH, Lilienfeld BG, Muller S, Muller E, Herbach N, Kessler B et al (2009) HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 87:35–43
Wheeler DG, Joseph ME, Mahamud SD, Aurand WL, Mohler PJ, Pompili VJ et al (2012) Transgenic swine: expression of human CD39 protects against myocardial injury. J Mol Cell Cardiol 52:958–961
Whitworth KM, Lee K, Benne JA, Beaton BP, Spate LD, Murphy SL et al (2014) Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biol Reprod 91:78
Wuensch A, Baehr A, Bongoni AK, Kemter E, Blutke A, Baars W et al (2014) Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs. Transplantation 97:138–147
Xin J, Yang H, Fan N, Zhao B, Ouyang Z, Liu Z et al (2013) Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs. PLoS ONE 8:e84250
Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M et al (2005) Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11:32–34
Yang YG, Sykes M (2007) Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 7:519–531
Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M et al (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89:168–173
Zayed H, Izsvak Z, Walisko O, Ivics Z (2004) Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 9:292–304
Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163(3):759–771
Zhou J, Shen B, Zhang W, Wang J, Yang J, Chen L et al (2014) One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering. Int J Biochem Cell Biol 46:49–55
Acknowledgments
This work was funded by the Deutsche Forschungsgemeinschaft (DFG) TRR 127 and the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence “REBIRTH”.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Niemann, H., Petersen, B. The production of multi-transgenic pigs: update and perspectives for xenotransplantation. Transgenic Res 25, 361–374 (2016). https://doi.org/10.1007/s11248-016-9934-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-016-9934-8